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Summary Patients and methods
Fifteen patients with macroscopic invasive thymomas or thymic
carcinomas were treated between 1969 and 1988 at Groote
Schuur Hospital. The results of histological examination of
these rumours were reviewed by one of the authors (R.c.).
The median age of the patients was 55 years (range 23 - 69
years). There were 7 men (47%). Seven of the patients were
white (47%), 6 were of mixed race (40%) and 2 were black
(13%). The patients were staged according to Table I: 12 were
stage 3 (80%) and 3 stage 4 (20%). Their initial symptoms are
shown in Table 11. All patients had an anterior mediastinal
mass. The 3 patients with stage 4 disease had pleural, pericar-
dial and lung metastases, respectively. Metastases were diag-
nosed at the time of thoracotomy in 1 of the 3 patients.
Fifteen patients (median age 55 years; range 23 - 69 years)
with macroscopic invasive thymoma or thymic carcinoma
were treated at Groote Schuur Hospital between 1969 and
1988. Stage 3 (macroscopically invasive) disease was present
in 12 patients (80%) and stage 4 (metastatic disease) in 3
(20%). Ten of the patients with stage 3 disease were treated
by combined surgery and full-dose mediastinal irradiation; in
2 resection was not possible and they were treated with irra-
diation alone. One of the patients with stage 3 disease
developed progressive thymoma (median follow-up 74
months). This patient and 2 others died; 1 from mediastinitis
after surgery for thymic carcinoma and 1 of unrelated disease.
Both patients treated by irradiation alone were free of disease
at follow-up. In the patients with stage 3 disease, the relapse
rate was 8% (crude) and the 5-year disease-free survival rate
86% (life table).
The patients with stage 4 disease received cisplatin-based
combination chemotherapy, which was combined with further
irradiation and debulking surgery in 2 of the 3 cases. These
patients died of malignant disease at between 5 and 42
months, although 1 had a temporary response to chemo-
therapy.
Tumour extent is the most important prognostic factor in
these patients. A multidisciplinary approach to therapy is
required.






TABLE I. STAGING SYSTEM2
Description
Macroscopic complete encapsulation, microscopic
invasion into but not through the capsule
Macroscopic invasion into surrounding fatty tissue
or mediastinal pleura or microscopic invasion
through the capsule .
Macroscopic invasion into neighbouring structures,
Le. pericardium, great vessels or lung
Pleural or pericardial dissemination of metastases
TABLE 11. CLINICAL SYNDROMES/SYMPTOMS OF
PRESENTATION
Thymomas are the most common tumour in the anterior
mediastinum. Although histologically bland and most often
encapsulated, they may be invasive or, rarely, metastatic.'
When the histological features of malignant disease are present,
the term thymic carcinoma is used.' The patients with epithelial
thymic rumours in the series reported below had macroscopic
invasion into surrounding structures, such as the pericardium,
great vessels and lungs.
The management of these rumours is controversial. At our
institution management has been based on surgical excision or
debulking, combined with mediastinal irradiation. Cisplatin
combination chemotherapy has been used in recent years for
patients with metastatic disease. A retrospective review was
undertaken to evaluate the local pattern of disease and review





Pulmonary symptoms, e.g. cough,
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Diagnosis was made by anterior mediastinotomy in 7
patients, by cervical mediastinoscopy in 1, by open biopsy in
3, and after resection in 4.
Thymomas consist of an admixture of cytologically bland
epithelial cells and reactive lymphocytes.3 Occasional mitoses
and cytological atypia are allowed. Three patients in this series
(20%) were diagnosed as having thymic carcinoma on review
on the basis of abundant 'mitoses, prominent nucleoli, vesicular
nuclei with dispersed chromatin, markedly increased nuclear
to cytoplasmic ratio and numerous foci of necrosis.4 All these
patients had stage 3 disease. The thymomas in this series (12
cases) were categorised according to the predominant cell type
into one of four histological subtypes: (I) predominantly epi-
theiial (more than 50% epithelial cells); (il) predominantly
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lymphocytic (more than 50% lymphocytes); (iiz) mixed (50% of
each cell type); and (iv) spindle-eelled. In this series the
thymomas were epithelial in 5 patients (33%), lymphocytic in 3
(20%), mixed in 3 (20%) and spindle-eelled in 1 (7%).
Treatment
In the patients with stage 3 disease, the planned therapy was
combined surgery and full-dose mediastinal irradiation. Resec-
tion was possible in 10 of the 12 patients. The patients with
stage 4 disease received cisplatin-based combination chemo-
therapy, which was combined with further irradiation and
debulking surgery in 2 of the 3 cases.
The patients' tumours were explored for surgical excision in
14 cases overall; via median sternotomy in 9 and thoracotomy
in 5 (4 right and 1 left). Excision was not attempted in 1
patient with stage 4 disease. Tumour excision or debulking
was not possible at surgery in 2 of the patients explored
because of mediastinal infiltration (both with stage 3 disease).
Tumour was found at surgery to be adherent to the pericar-
dium in 10 patients, pleura in 7, major vessels in 6, lung in 4,
phrenic nerve in 3, sternum in 3, lung hilum in 2, oesophagus
in 1 and the trachea in 1. .
In the 12 patients undergoing resection (10 with stage 3 and
2 with stage 4 disease), -gross tumour was known to remain at
the termination· of the procedure in 6 patients. Concomitant
lung resection was performed in 4 cases and segments of major
vessels were removed and reconstructed in 2 patients.
Irradiation was given in the stage 3 cases, pre- and post-
operatively in 8 patients, and postoperatively only in 4. The 2
patients with stage 3 disease in whom resection was not
possible, were treated with irradiation alone. Irradiation was
via anterior and posterior portals on cobalt 60 with shielding
of the spinal cord at tolerance. The total radiation dose was in
the order of 50 Gy in 2,5 Gy fractions. Patients treated with
pre-operative irradiation received 25 Gy pre-operatively and
25 Gy postoperatively.
Results
In the patients with stage 3 disease, 9 of 12 are alive and free
of disease at a median follow-up of 74 months (range 12 - 224
months). In the stage 3 patients who died there was 1 post-
operative death (see below), 1 from coincidental cardiovascular
disease while free of thymoma at 9 months and 1 from
progressive thymoma. This patient relapsed at 20 months with
lung disease and died of malignant disease at 63 months. She
had presented with an epithelial tumour and had debulking
. surgery and pre- and postoperative irradiation. In the patients
with stage 3 disease, the relapse rate was 8% (crude) and the
5-year disease-free survival rate was 86% (life table).
One patient with thymic carcinoma and an extensive tumour,
thought to be irresectable at the time of surgery, died after
operation. A staphylococcal mediastinitis led to fulminant
sepsis.
All the patients with stage 4 disease died of malignant
disease between 5 and 42 months after diagnosis. One of these
patients, with a spindle-eell tumour, had an objective response
to chemotherapy, which was of 20 months' duration.
Discussion
Invasive epithelial tumours of the thymus are rare - only 15
cases were seen at our institution over a 20-year period. The
most direct method of establishing the diagnosis is anterior
mediastinotomy' and this was the most frequently used method
in this series. Distant metastases are relatively rare in patients
with thymomas. Three patients in this series had metastases at
presentation (all intrathoracic) and 1 of the patients with stage
3 disease developed metastases during follow-up. This empha-
sises the importance of achieving local control with therapy.
The treatment of invasive disease is controversial. Total
surgical excision is adequate for patients with stage 1 thymoma
(non-invasive) with an anticipated 100% local control rateY
This procedure is possible in some patients with invasive
tumours but the reported rates of subsequent relapse, however,
vary widely.6-s It seems likely that local control rates are
improved by the addition of full dose mediastinal irradiation.
Curran er aJ.2 have pooled the results from 7 studies and
reported a 28% relapse rate for stage 2 and 3 thymomas treated
by total excision alone and a relapse rate of 5% when this was
combined with irradiation.
Patients whose tumours are not totally resectable are usually
treated by irradiation. A number of small series have been
reported in which prolonged disease-free survival was
noted.9- 11 It is unclear, however, whether these patients should
be treated by irradiation alone or irradiation combined with
aggressive debulking surgery. Curran er aJ.2 found in their
series of 20 patients, 10 of whom had undergone postoperative
irradiation after biopsy alone and 10 subtotal resection, no
difference in mediastinal recurrence rate (20%) or overall
relapse rate (40 - 50%).2 We achieved local control in both
patients treated with surgery followed by radiotherapy. Too
few cases have, however, been treated by biopsy and irradiation
alone and we therefore elect to continue with aggressive
surgical tumour resection. This allows postoperative irradiation
to be given with smaller treatment portals.
Irradiation may be given in a split course (pre-operatively
and postoperatively) or in a single continuous course post-.
operatively. Pre-operative irradiation may facilitate surgery
through tumour shrinkage and does not appear to cause
increased complications. The known areas of tumour invasion
should be marked with clips at surgery to facilitate radiation.
In this study of aggressive surgery where possible combined
with mediastinal irradiation the relapse rate in patients with
stage 3 disease was 8% and the 5-year disease-free survival rate
was 86%.
The prognostic significance of histological subrypes has
been the subject of considerable debate. Opinions vary from
no correlation12,13 to studies showing that epithelial subtypes
confer a poorer prognosis.3,14,15 It would seem from published
reports and our series that capsular invasion together with
intra-operative or biopsy evidence of spread (i.e. metastases) is
the most important progno~tic factor. 1This far outweighs cell
type, pleomorphism and mitotic count.
Chemotherapy has a role in patients with metastatic disease
and reponses may be seen. 1S,17
This series supports the need for a multidisciplinary
approach in treatment of patients with invasive thymic
tumours.
The support of the National Cancer Association of South Mrica
is acknowledged. We thank Mrs D. Godley for typing the manu-
script.
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Summary
This autopsy-based study defined the prevalence and age
distribution of peripheral pulmonary hamartomas in 47635
southern African miners examined between 1975 and 1988.
The prevalence rate for white miners was 7,5/1000 and for
black miners 1,1/1 000. When directly standardised to the
white men in the general population. the rates for white and
black miners were 7,2 and 5,5/1 000, respectively. The preva-
lence of peripheral pulmonary hamartomas in both groups
increased with age, from 0,8/1000 in the third decade to
12,0/1000 in the eighth decade. The study showed a much
higher prevalence of peripheral pulmonary hamartomas for
whites than previously reported. Furthermore, it documented
the occurrence of these benign lung tumours in blacks, a fact
that has previously been questioned. There appeared to be
no significant difference in prevalence and age distribution
between white and black miners, although the database for
the black group was deficient for the later decades of life.
and age distribution of peripheral pulmonary hamartomas are
based on cases referred for investigation of solitary pulmonary
nodules.
In a recent South Mrican series,! 14 of 530 patients (2,6%)
with coin lesions undergoing fme-needle aspiration cytology
were found to have peripheral pulmonary hamartomas. No
cases occurred in blacks, raising the question whether this is a
true reflection of disease prevalence. As far as we are aware,
the racial distribution of these lesions has not previously been
addressed.
The prevalence and age distribution of peripheral pulmonary
hamartomas in an autopsy-based series of black and white
southern Mrican miners is described.
Subjects and methods
S AIr Med J 1991; 79: 247-249.
Peripheral pulmonary hamartomas are benign lesions, usually
detected radiologically as incidental findings in asymptomatic
individuals. They enter into the differential diagnosis of coin
lesions in the lung; most reports concerning the prevalence
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Autopsy examination of the cardiorespiratory organs for com-
pensation purposes is required by law for all miners and ex-
miners who die in South Mrica, provided the next of kin
agree.2 The goldmining industry, which has the largest wQrk-
force in South Mrica, accounts for approximately 80% of these
autopsies. Other types of mining, including platinum, asbestos
and coal, as well as industries involved in primary ore
processing, are covered by this legislation.
Comprehensive macroscopic and microscopic examination
of the heart and lungs is undertaken by the pathology service
of the National Centre for Occupational Health. Results of the
autopsies are recorded on structured, numerically coded reports
and entered in a computerised system, the PATHAUT data-
base.3
The autopsy records from 1975 to 1988 were reviewed for
all cases of peripheral pulmonary hamartomas. The age and
race distribution of cases was compared with that of the whole
autopsied population.
Monality statistics for the total South Mrican male popula-
tion for 1986 and 1987 were obtained from Central Statistical
